PHK
ALDX icon

Point72 Hong Kong’s Aldeyra Therapeutics ALDX Stock Holding History

Point72 Hong Kong’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,702
Closed -$31K – 1795
2021
Q4 		$31K Buy
+7,702
New +$58.7K ﹤0.01% 1464
2021
Q3 		– Sell
-298
Closed -$3K – 1934
2021
Q2 		$3K Buy
+298
New +$3.58K ﹤0.01% 1817
2020
Q1 		– Sell
-683
Closed -$4K – 922
2019
Q4 		$4K Buy
+683
New +$3.94K ﹤0.01% 1048

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Point72 Hong Kong's ALDX Position: Q1 2022 in Review

Point72 Hong Kong sold out of Aldeyra Therapeutics (ALDX) in Q1 2022, closing a stake of 7,702 shares — an estimated $31K sold.

Point72 Hong Kong first reported a position in ALDX in Q4 2019 and held it in 3 quarters. The position peaked at $31K in Q4 2021. 111 funds tracked by Wall St. Rank hold ALDX as of Q1 2022.

  • Point72 Hong Kong reported no remaining Aldeyra Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 7,702 Aldeyra Therapeutics shares in Q1 2022, an estimated $31K.
  • Point72 Hong Kong first reported a position in Aldeyra Therapeutics in Q4 2019 and held it in 3 quarters.
  • Point72 Hong Kong's Aldeyra Therapeutics position peaked at $31K in Q4 2021.
  • 111 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2022.

Based on Point72 Hong Kong's 13F filing for Q1 2022, filed 16 May 2022.